Tag: Laboratories

CMS issues guidance on broad waivers and flexibilities related to COVID-19.

On March 30,CMS announced a broad range of waivers and flexibilities for providers as the country is faced with the COVID-19 public health emergency. CMS has developed provider specific fact sheets on the flexibilities during this PHE. Laboratories...

Congress passes CARES Act

On March 27, 2020, the President signed the Coronavirus Aid, Relief, and Economic Security (CARES) Act. The CARES Act represents the third largest stimulus bill passed by Congress in response to the COVID-19 pandemic and with $2 trillion in allocatio...

CMS Releases MLN Article to Assist with Determining Applicable Laboratory Status